Cargando…

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease

The candidate prostate cancer susceptibility gene HPC2/ELAC2 has two common coding polymorphisms: (Ser→Leu 217) and (Ala→Thr 541). The Thr541 variant in the HPC2/ELAC2 gene has previously been reported to be at an increased frequency in prostate cancer cases. To evaluate this hypothesis we genotyped...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meitz, J C, Edwards, S M, Easton, D F, Murkin, A, Ardern-Jones, A, Jackson, R A, Williams, S, Dearnaley, D P, Stratton, M R, Houlston, R S, Eeles, R A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376179/ https://www.ncbi.nlm.nih.gov/pubmed/12373607 http://dx.doi.org/10.1038/sj.bjc.6600564

Ejemplares similares

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
por: Kote-Jarai, Z, et al.
Publicado: (2011)

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours
por: Sodha, N, et al.
Publicado: (2002)

Polymorphisms of HPC2/ELAC2 and SRD5A2 (5α-Reductase Type II) Genes in Prostate Cancer
por: İzmirli, M, et al.
Publicado: (2011)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

A physical analysis of the Y chromosome shows no additional deletions, other than Gr/Gr, associated with testicular germ cell tumour
por: Linger, R, et al.
Publicado: (2007)

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers
por: Kadouri, L, et al.
Publicado: (2008)

The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome
por: Clyne, M, et al.
Publicado: (2009)

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers
por: Kadouri, L, et al.
Publicado: (2004)

Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers
por: Kote-Jarai, Z, et al.
Publicado: (2006)

Role of MC1R variants in uveal melanoma
por: Hearle, N, et al.
Publicado: (2003)

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.
por: Dunsmuir, W. D., et al.
Publicado: (1998)

Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma
por: Hubner, R A, et al.
Publicado: (2007)

Prognostic significance of folate metabolism polymorphisms for lung cancer
por: Matakidou, A, et al.
Publicado: (2007)

Mutation analysis of the MSMB gene in familial prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2010)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer
por: Benusiglio, P R, et al.
Publicado: (2006)

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Sinilnikova, O M, et al.
Publicado: (2009)

Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population
por: Lesueur, F, et al.
Publicado: (2006)

No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.
por: Edwards, S. M., et al.
Publicado: (1997)

Search for inherited susceptibility to radiation-associated meningioma by genomewide SNP linkage disequilibrium mapping
por: Hosking, F J, et al.
Publicado: (2011)

CASP8 variants D302H and −652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population
por: Pittman, A M, et al.
Publicado: (2008)

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
por: Osorio, A, et al.
Publicado: (2011)

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
por: Agalliu, I, et al.
Publicado: (2007)

Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas
por: Barker, K T, et al.
Publicado: (2002)

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website
por: Bamford, S, et al.
Publicado: (2004)

TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk
por: Skoglund Lundin, J, et al.
Publicado: (2009)

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
por: Jakubowska, A, et al.
Publicado: (2012)

Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3
por: Hughes, S, et al.
Publicado: (2005)

COSMIC 2005
por: Forbes, S, et al.
Publicado: (2006)

Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer
por: Cox, D G, et al.
Publicado: (2004)

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years
por: Robertson, L, et al.
Publicado: (2012)

Chorea, psychosis, acanthocytosis, and prolonged survival associated with ELAC2 mutations
por: Paucar, Martin, et al.
Publicado: (2018)

ELAC2/RNaseZ-linked cardiac hypertrophy in Drosophila melanogaster
por: Migunova, Ekaterina, et al.
Publicado: (2021)

Comprehensive analysis of common mitochondrial DNA variants and colorectal cancer risk
por: Webb, E, et al.
Publicado: (2008)

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer
por: Quaye, L, et al.
Publicado: (2009)

Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
por: Leongamornlert, D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ifpbho9nhka7apgb7n3sdogeed